Get ready to walk in one of the largest events to help put an end to Alzheimer's. The Alzheimer's Association is calling on ...

Alzheimer's disease is a neurological condition that gradually impairs thinking and memory abilities. Nearly 7 million ...

The European Medicines Agency’s human medicines committee is re-examining the marketing authorisation application for the ...

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

In this GEN webinar, our expert speaker, Dr. Sterling Johnson, will discuss multi-plex blood biomarker assays, new discoveries in AD research from a large-scale study, and opportunities for early ...

According to Alzheimer’s Disease International and Dementia Forecasting Collaborators, Alzheimer’s Disease is currently the ...

According to the National Institute on Aging, mild cognitive impairment (MCI) is when an older person has more problems with ...

According to the National Institute on Aging, mild cognitive impairment (MCI) is when an older person has more problems with ...

While Alzheimer's disease is irreversible, a plant-based diet has a huge role to play in its prevention and delaying its ...

The company aims to streamline its own lab operations while also enabling distribution of its Alzheimer's tests to outside labs both in the US and abroad.

The Triangulation of Innovative Methods to End Alzheimer's Disease project will use large, diverse datasets to examine whether interventions targeting alcohol use, depression, vision or hearing ...

Weill Cornell Medicine investigators have found that two genetic variants that confer high risk of Alzheimer's disease (AD) together trigger a harmful ...